home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Gene Therapy Vaccine For Cancer

  April, 8 2002 8:30
your information resource in human molecular genetics
T lymphocytes of the immune system are vital to bodily defenses against viruses and cancer. T lymphocytes are activated in part by molecules called co-stimulatory signals, of which 4-1BB is one example. However, tumor cells are cleverly able to turn off the effects of some co-stimulatory molecules, thus ensuring their own survival.

Recent experiments in mice have shown that binding a monoclonal antibody to 4-1BB activates this co-stimulatory molecule and triggers a strong immune response. Based on this knowledge, Karl Erik Hellstrom and colleagues at the Pacific Northwest Research Institute in Seattle have developed a form of gene therapy to treat cancer (Nature Medicine, Vol. 8, No. 4, 01 Apr 02, p. 343). They inserted a gene for a fragment of the antibody to 4-1BB into mouse melanoma cells and used these ‘transfected’ cells to vaccinate other mice.

The inoculation stimulated the immune system against cancer cells and vaccinated mice were able to reject other tumors. Lieping Chen of the Mayo Clinic discusses the potential of this gene therapy vaccine to treat human cancers (p. 333).

Dr. Karl E. Hellström
Pacific Northwest Research Institute
720 Broadway
Seattle, WA 98122
Tel: +1 206 726 8747
Fax: +1 206 860 6773
Email: khellstrom@pnri.org

Dr. Lieping Chen
Department of Immunology
Mayo Clinic
200 First St, SW
Guggenheim 342B
Rochester, MN 55905
Tel: +1 507 538 0013
Fax: +1 507 284 1637
Email Address: chen.lieping@mayo.edu

(C) Nature Medicine press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.